Chargement en cours...
Radiologic criteria of response to systemic treatments for hepatocellular carcinoma
Sorafenib has been the only approved systemic therapy for hepatocellular carcinoma until very recently. However, the radiologic assessment of its biological activity is a disputed matter as at least five different criteria have been proposed. In this review, we describe the characteristic of the Res...
Enregistré dans:
| Publié dans: | Hepat Oncol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Future Medicine Ltd
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096444/ https://ncbi.nlm.nih.gov/pubmed/30191059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2017-0018 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|